Materials · Industrial Organic Chemicals

IFF International Flavors & Fragrances SEC Filings & Insider Trading Activity 2026

company
CIK 5125397 filings
S&P 500

IFF at a glance

International Flavors & Fragrances (IFF, SEC CIK 51253) filed its latest 10-K annual report on February 27, 2026, a 10-Q quarterly report on November 3, 2026, an 8-K current report on November 3, 2026 and Form 4 insider filings as recently as November 4, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • For the fiscal year ended December 31, 2025 (FY2025), International Flavors & Fragrances (IFF) reported revenue of $10.9 billion (down 5.2% from FY2024) and a net loss of $361.0 million. Diluted EPS was -$1.41.
  • As of September 30, 2026, 34 institutional investment managers tracked by SignalX reported holding International Flavors & Fragrances (IFF) shares worth $8.3 billion in 13F-HR filings.
  • The most recent insider open-market sale reported on Form 4 was by Teles de Mendonca Ana Paula on August 17, 2026 of 5,718 shares at $83.19 per share.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Revenue · FY2025
$10.9B
−5.2% vs prior year
Insiders · 90 days
0 buys · 0 sells
No open-market trades
13F holders
34 funds
$8.3B · −3 vs prior quarter
Latest 8-K
Nov 3, 2026
Item 2.02

AI 10-K Annual Report Analysis

Latest 10-K, fiscal year ended Dec 31, 2025

Full analysis →

Business Overview

  • Core model: leading creator/manufacturer of flavors, food ingredients, biotechnology-derived ingredients (enzymes, cultures, probiotics), and scents; $10.89B FY2025 sales
  • Structural change: former Nourish segment split into two new segments; Taste and Food Ingredients, effective January 1, 2025
  • Portfolio divestiture: Pharma Solutions segment fully exited via two divestitures completed May 1 and May 9, 2025, narrowing focus to four core segments
  • ~21,500 employees globally as of December 31, 2025, with ~3,000 dedicated to R&D; U.S. represents 28% of sales, no single country exceeds 10%
  • EcoVadis Gold sustainability rating placing IFF in top 5% of assessed companies; CDP Climate A-list designation for tenth time since 2015

Risk Factors

  • Antitrust investigations ongoing in multiple countries + class action lawsuits in U.S. and Canada; enforcement could bring significant fines and business restrictions
  • Total debt ~$5.994B as of Dec 31, 2025; dividend cut ~50% in Feb 2024 to accelerate deleveraging
  • Goodwill impairment charge of $1.153B recorded in Food Ingredients segment following 2025 segment restructuring; $14.3B intangible assets/goodwill remain at risk
  • Reliance on limited suppliers/regions for essential oils, botanical extracts, and petroleum-based chemicals; tariffs, U.S.-China tensions, and Russia-Ukraine war strain margins
  • ~72% of 2025 net sales outside U.S.; currency volatility and OECD Pillar Two 15% minimum tax (applicable to IFF given scale) add cross-border tax and FX exposure

Management Discussion & Analysis

  • Revenue $10.89B in 2025, down 5% reported vs $11.484B in 2024; comparable currency neutral basis up 2%, with ~$757M drag from divestitures
  • Gross margin 36.2% vs 35.9% in 2024; operating margin swung to -3.5% vs 6.7% in 2024, driven by $1.153B Food Ingredients goodwill impairment
  • Best segment: Health & Biosciences, EBITDA margin 26.7% vs 26.2%; worst: Food Ingredients, sales -3% and $1.153B goodwill impairment recorded
  • Operating cash flow $850M (7.8% of sales) vs $1.07B in 2024; $2.0B Senior Notes repurchased; dividends $409M ($1.60/share); buybacks $38M; capex guided ~6% of sales in 2026
  • Key risks: ongoing Food Ingredients division sale process, tariffs/trade disruptions, FX exposure, Health & Biosciences goodwill headroom thin at 9% above carrying value

AI summary of the IFF 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K

AI 10-Q Quarterly Report Analysis

Latest 10-Q, quarter ended Sep 30, 2026

Risk Factors

  • No material changes to risk factors since the 2025 Form 10-K
  • Carried-forward risks include regulatory, operational, competitive, market, liquidity, debt, currency, and concentration exposures

Management Discussion & Analysis

  • Q3 revenue $1.942B, up $73M or 4% YoY, driven by 5% consolidated volume growth
  • Gross margin 42.5% vs 42.8% YoY, operating margin 8.2% vs 10.2%
  • Best segment: Scent revenue $689M, up 6%; adjusted EBITDA $139M, up 9%
  • Worst segment: Health & Biosciences revenue $566M, up 1%; adjusted EBITDA $136M, up 1%
  • Cash $519M vs $590M at December 31; nine-month operating cash flow $820M vs $532M, with $500M ASR and $449M capital additions

AI summary of the IFF 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K

AI 8-K Current Report Analysis

The most recent material events, by 8-K item

Filed Nov 3, 2026Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • Third-quarter 2026 financial results announced for quarter ended September 30, 2026
  • Management webcast scheduled November 4, 2026 at 9:00 a.m. ET

Item EX-99.1: Item EX-99.1

  • Q3 sales $1.94B, up 4%; comparable currency-neutral sales rose 5%, showing broad-based volume-led demand
  • Adjusted operating EBITDA $403M, up 6% currency-neutral; margin 20.8% versus 20.5% prior year
Filed Nov 3, 2026Full analysis →

Item 5.02: Departure/Appointment of Directors or Principal Officers

  • Transaction-linked incentives total $2.45 million for four named executives, adding costs beyond regular compensation programs
  • CEO J. Erik Fyrwald received $700,000 in RSUs, vesting after three years and settled in company shares

Item 5.03: Amendments to Articles of Incorporation or Bylaws

  • Effective October 28, 2026, board-approved bylaws permit fully virtual stockholder meetings
  • Remote participation also authorized for meetings held at physical locations
Filed Aug 4, 2026Full analysis →

Item 8.01: Other Events

  • IFF agreed to sell its Food Ingredients business to CVC Capital Partners funds
  • IFF retaining approximately 10% minority interest preserves future value participation and commercial collaboration

Item 2.02: Results of Operations and Financial Condition

  • Q2 2026 financial results released for quarter ended June 30, 2026
  • Management webcast scheduled August 5, 2026 at 9:00 a.m. ET

Item EX-99.1: Item EX-99.1

  • Q2 sales $1.95B, up 2% reported and 6% currency-neutral comparable, with broad-based growth across continuing operations
  • Adjusted operating EBITDA $408M, margin 20.9%, up from 19.7% including discontinued operations, signaling portfolio mix improvement

AI summaries of IFF 8-K current reports filed with the SEC. What 8-K item codes mean

SignalX for IFF

Don't miss the next IFF filing

  • Alerts as it files. A push when IFF files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut IFF, by share count.
  • Ask anything. An AI agent that reads every IFF filing and answers with sources.

IFF alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
Khan MehmoodANov 2, 2026-
Fyrwald J ErikANov 2, 2026-
Teles de Mendonca Ana PaulaSellAug 17, 2026$83.19
Birenkrant MarcSellAug 7, 2026$85.00
DeVeau MichaelSellAug 6, 2026$85.55
FRIBOURG PAUL JBuyJun 1, 2026$74.28
FRIBOURG PAUL JBuyJun 1, 2026$74.49
Borg DeborahFMay 4, 2026$70.09

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2023FY2024FY2025
Profitability
Revenue-$11.5B$10.9B
Gross Profit-$4.1B$3.9B
Operating Income-$766.0M-$382.0M
Net Income-$243.0M-$361.0M
Gross Margin-35.9%36.2%
Op. Margin-6.7%-3.5%
Net Margin-2.1%-3.3%
Balance Sheet
Total Assets$31.0B$28.7B$25.5B
Equity-$13.9B$14.2B
ROE-1.8%-2.6%
Per Share
EPS-$0.95$-1.41
Cash Flow
Operating CF-$1.1B$850.0M
CapEx$503.0M$463.0M$594.0M

Source: XBRL data in International Flavors & Fragrances (IFF)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q3 2026

Aggregate IFF share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
IFF shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q3 202634$8.32B
Q2 202637$8.10B
Q1 202635$7.10B
Q4 202532$6.83B
Q3 202536$5.86B
Q2 202533$6.90B
Q1 202531$5.16B
Q4 202427$5.16B
Position changes: Q2 2026 → Q3 2026
Top Buyers
Top Sellers
New Positions

Source: 13F-HR filings on SEC EDGAR (aggregated from 265 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

IFF filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
4Nov 4, 2026--
8-KNov 3, 2026Analysis-
8-KNov 3, 2026Analysis-
4Nov 3, 2026--
10-QNov 3, 2026Analysis
4Aug 19, 2026--
4Aug 10, 2026--
4Aug 7, 2026--
8-KAug 4, 2026Analysis-
10-QAug 4, 2026Analysis
8-KAug 4, 2026Analysis-
8-KJun 23, 2026Analysis-
4Jun 2, 2026-
8-KJun 1, 2026Analysis
4May 6, 2026-
4May 6, 2026-
4May 6, 2026-
4May 6, 2026-
4May 6, 2026-
10-QMay 5, 2026Analysis
4May 5, 2026--
8-KMay 5, 2026Analysis-
4May 5, 2026--
4May 5, 2026--
4May 5, 2026--

Related Materials companies

All Materials →

IFF SEC filings: frequently asked questions

Which institutions hold IFF stock?

As of September 30, 2026, the largest International Flavors & Fragrances (IFF) holders among the 13F filers tracked by SignalX were BlackRock ($1.9 billion), Vanguard Capital Management LLC ($1.4 billion), State Street Corp ($1.1 billion), Vanguard Portfolio Management LLC ($967.6 million), Invesco Ltd ($776.3 million). 13F-HR reports are filed up to 45 days after each quarter ends.

What was IFF's revenue in fiscal year 2025?

For the fiscal year ended December 31, 2025 (FY2025), International Flavors & Fragrances (IFF) reported revenue of $10.9 billion (down 5.2% from FY2024) and a net loss of $361.0 million. Diluted EPS was -$1.41. The figures come from the XBRL data in the 10-K.

What are the main risks in IFF's latest 10-K?

In the 10-K filed February 27, 2026, International Flavors & Fragrances (IFF) flagged: Antitrust investigations ongoing in multiple countries + class action lawsuits in U.S. and Canada; enforcement could bring significant fines and business restrictions. Total debt ~$5.994B as of Dec 31, 2025; dividend cut ~50% in Feb 2024 to accelerate deleveraging. (AI summary of the Risk Factors section.)

What did IFF report in its latest 8-K?

International Flavors & Fragrances (IFF) filed an 8-K on November 3, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Third-quarter 2026 financial results announced for quarter ended September 30, 2026.

What are the latest IFF SEC filings?

International Flavors & Fragrances (IFF) filed its latest 10-K annual report on February 27, 2026, a 10-Q quarterly report on November 3, 2026, an 8-K current report on November 3, 2026 and a Form 4 insider filing on November 4, 2026.

What is IFF's SEC CIK number?

International Flavors & Fragrances (IFF)'s SEC Central Index Key (CIK) is 51253. EDGAR lists every IFF filing under that number.

Ask anything about IFF

The research agent reads IFF's filings, financials, insider trades and 13F holders, then answers with sources.